Auditing and benchmarks in screening and diagnostic mammography.
Radiologists can use outcome data such as cancer size and stage to determine how well their own practice provides benefit to their patients and can use measures such as screening recall rates and positive predictive values to assess how well adverse consequences are being contained. New data on national benchmarks for screening and diagnostic mammography in the United States allow radiologists to evaluate their own performance with respect to their peers. This article discusses recommended outcome values in the United States and Europe, current Mammography Quality Standards Act audit requirements, and Institute of Medicine proposals for future requirements.
Feig
Stephen A
SA
University of California, Irvine School of Medicine, Orange, CA, USA. sfeig@uci.edu
D019985:Benchmarking; D001943:Breast Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology; D005060:Europe; D005260:Female; D006801:Humans; D008327:Mammography / Q000592:standards*; D008403:Mass Screening / Q000592:standards*; D008485:Medical Audit; D009367:Neoplasm Staging; D017063:Outcome Assessment, Health Care / Q000592:standards; D011237:Predictive Value of Tests; D011785:Quality Assurance, Health Care / Q000331:legislation & jurisprudence / Q000592:standards; D011871:Radiology / Q000592:standards; D014481:United States